PROX1 and metastatic malignant neoplasm in the lymph nodes: We observed significantly higher PROX1 and α-SMA expression in patients of CRC with lymphatic invasion or lymph node metastasis compared with those of CRC without lymphatic invasion and lymph node metastasis (Table 2).